Form 4: Marimed COO Timothy Shaw Converts RSUs, Sells Shares for Tax

Marimed Inc.'s Chief Operating Officer, Timothy Shaw, converted Restricted Stock Units into common stock and subsequently sold a portion to cover tax obligations.

Summary

• Timothy Shaw, Chief Operating Officer of Marimed Inc., converted 81,772 Restricted Stock Units (RSUs) into common stock on September 15, 2025.
• 24,001 shares of common stock were withheld by the issuer to satisfy tax withholding obligations in connection with the RSU vesting, at a price of $0.1374 per share.
• Following these transactions, Timothy Shaw directly beneficially owns 9,048,361 shares of common stock.
• An additional 2,000,000 shares are indirectly beneficially owned through the Shaw Family Trust, though Mr. Shaw disclaims beneficial ownership of these securities.
• The RSUs converted were granted on May 23, 2025, and the remaining RSUs are scheduled to vest on December 15, 2025.

Sentiment

Score: 6

Explanation: This is a routine insider transaction involving the vesting of Restricted Stock Units and a subsequent sale of shares to cover tax obligations. It reflects a standard compensation event rather than a significant positive or negative operational or strategic development for the company.

Positives

• Vesting of 81,772 Restricted Stock Units (RSUs) for Chief Operating Officer Timothy Shaw, indicating achievement of performance or tenure milestones.

Negatives

• Disposition of 24,001 shares of common stock to cover tax withholding obligations, reducing direct beneficial ownership.

Future Outlook

Remaining Restricted Stock Units (RSUs) are scheduled to vest on December 15, 2025, in accordance with the terms of an award agreement.

Management Comments

• The Reporting Person disclaims beneficial ownership of these securities [held by the Shaw Family Trust], and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Industry Context

This Form 4 filing represents a routine insider transaction, common for executives receiving equity compensation. The conversion of Restricted Stock Units (RSUs) and subsequent sale of shares for tax purposes are standard practices in executive compensation across various industries.

Related Party Transactions

• Indirect beneficial ownership of 2,000,000 shares through the Shaw Family Trust, where the reporting person's spouse is the trustee and the shares benefit the reporting person's children. The reporting person disclaims beneficial ownership of these securities.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine compensation event. The RSU conversion represents a minor increase in outstanding shares, partially offset by the tax-related disposition.
• Employees (specifically Timothy Shaw): Realization of compensation through the vesting of Restricted Stock Units.

Next Steps

• Remaining Restricted Stock Units (RSUs) will vest on December 15, 2025.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of Restricted Stock Units (RSUs) and a subsequent sale of shares to cover tax obligations. Such transactions are common for executives and typically do not indicate a change in the company's fundamental outlook or performance. The vesting of RSUs is a pre-scheduled compensation event, and the tax-related sale is a standard practice. There are no new strategic insights, financial performance indicators, or significant shifts in insider sentiment that would warrant a change in investment recommendation based solely on this filing. Therefore, a 'hold' recommendation is appropriate as this filing does not provide new information to alter an existing investment thesis.

Keywords

MARIMED, MRMD, Timothy Shaw, COO, Form 4, RSU, Restricted Stock Units, insider transaction, stock sale, tax withholding, beneficial ownership